Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1989; Volume 35,Issue 2
  • You have access
    Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    J Ellis and M Seidenberg
    Molecular Pharmacology February 1989, 35 (2) 173-176;
  • You have access
    Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    J M Woynarowski, M McHugh, R D Sigmund and T A Beerman
    Molecular Pharmacology February 1989, 35 (2) 177-182;
  • You have access
    Identification of an intracellular pool of gamma-aminobutyric acidA/benzodiazepine receptors en route to the cell surface of brain neurons in culture.
    C Czajkowski and D H Farb
    Molecular Pharmacology February 1989, 35 (2) 183-188;
  • You have access
    meta- and para-isothiocyanato-t-butylbicycloorthobenzoate: irreversible ligands of the gamma-aminobutyric acid-regulated chloride ionophore.
    A H Lewin, B R de Costa, K C Rice and P Skolnick
    Molecular Pharmacology February 1989, 35 (2) 189-194;
  • You have access
    Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation.
    S K Fisher, L M Domask and R M Roland
    Molecular Pharmacology February 1989, 35 (2) 195-204;
  • You have access
    A metactoid sensitization model to describe multiple receptors linked to a common response: application to histamine receptors coupled to [3H]cyclic AMP accumulation in guinea pig cortex.
    M N Gannon, L B Hough and H Weinstein
    Molecular Pharmacology February 1989, 35 (2) 205-213;
  • You have access
    Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists.
    T P Kenakin and P H Morgan
    Molecular Pharmacology February 1989, 35 (2) 214-222;
  • You have access
    N-methylanatoxinol isomers: derivatives of the agonist (+)-anatoxin-a block the nicotinic acetylcholine receptor ion channel.
    K L Swanson, Y Aracava, F J Sardina, H Rapoport, R S Aronstam and E X Albuquerque
    Molecular Pharmacology February 1989, 35 (2) 223-231;
  • You have access
    The binding of nonintercalative drugs to alternating DNA sequences.
    F Gago, C A Reynolds and W G Richards
    Molecular Pharmacology February 1989, 35 (2) 232-241;
  • You have access
    Investigations into the biochemical effects of region-specific nephrotoxins.
    K P Gartland, F W Bonner and J K Nicholson
    Molecular Pharmacology February 1989, 35 (2) 242-250;
  • You have access
    Joint experimental and theoretical investigation of the comparative DNA binding affinities of intercalating anthracycline derivatives.
    N Gresh, B Pullman, F Arcamone, M Menozzi and R Tonani
    Molecular Pharmacology February 1989, 35 (2) 251-256;
  • You have access
    Theoretical study of the protonation and tautomerization of adenosine, formycin, and their 2-NH2 and 2-F derivatives: functional implications in the mechanism of reaction of adenosine deaminase.
    M Orozco, E I Canela and R Franco
    Molecular Pharmacology February 1989, 35 (2) 257-264;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 2
1 Feb 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics